van Oort I - Search Results

1

Oligometastatic Prostate Cancer: Results of a Dutch Multidisciplinary Consensus Meeting.

Aluwini SS, Mehra N, Lolkema MP, Oprea-Lager DE, Yakar D, Stoevelaar H, van der Poel H; Dutch Oligometastatic Prostate Cancer Working Group; Busstra M, de Jong IJ, de Reijke T, de Vries K, Heijmink S, Jenster G, Klaver S, Kneppers J, Lavalaye J, Leyten G, Moonen L, Nagaraj J, Noordzij W, Osanto S, Oving I, Schaake E, Scheenen T, Schoots I, Sedelaar M, Somford D, van den Berkmortel F, van der Hulle T, van der Voort van Zyp J, van Leeuwen P, van Moorselaar J, van Oort I, Vogel W, Westgeest H. Aluwini SS, et al. Among authors: van moorselaar j, van oort i, van der poel h, van den berkmortel f, van der voort van zyp j, van der hulle t, van leeuwen p. Eur Urol Oncol. 2020 Apr;3(2):231-238. doi: 10.1016/j.euo.2019.07.010. Epub 2019 Aug 8. Eur Urol Oncol. 2020. PMID: 31401014

2

Does the tertiary Gleason pattern influence the PSA progression-free interval after retropubic radical prostatectomy for organ-confined prostate cancer?

van Oort IM, Schout BM, Kiemeney LA, Hulsbergen CA, Witjes JA. van Oort IM, et al. Eur Urol. 2005 Oct;48(4):572-6. doi: 10.1016/j.eururo.2005.06.003. Eur Urol. 2005. PMID: 16046051

3

[Multiparametric MRI for prostate cancer screening].

Hoeks CM, Fütterer JJ, Somford DM, van Oort IM, Huisman H, Barentsz JO. Hoeks CM, et al. Ned Tijdschr Geneeskd. 2009;153:B487. Ned Tijdschr Geneeskd. 2009. PMID: 20003566 Review. Dutch.

4

Magnetic resonance imaging guided prostate biopsy in men with repeat negative biopsies and increased prostate specific antigen.

Hambrock T, Somford DM, Hoeks C, Bouwense SA, Huisman H, Yakar D, van Oort IM, Witjes JA, Fütterer JJ, Barentsz JO. Hambrock T, et al. J Urol. 2010 Feb;183(2):520-7. doi: 10.1016/j.juro.2009.10.022. Epub 2009 Dec 14. J Urol. 2010. PMID: 20006859

5

Feasibility of 3T dynamic contrast-enhanced magnetic resonance-guided biopsy in localizing local recurrence of prostate cancer after external beam radiation therapy.

Yakar D, Hambrock T, Huisman H, Hulsbergen-van de Kaa CA, van Lin E, Vergunst H, Hoeks CM, van Oort IM, Witjes JA, Barentsz JO, Fütterer JJ. Yakar D, et al. Invest Radiol. 2010 Mar;45(3):121-5. doi: 10.1097/RLI.0b013e3181c7bcda. Invest Radiol. 2010. PMID: 20065860

6

Prognostic relevance of number and bilaterality of positive surgical margins after radical prostatectomy.

Somford DM, van Oort IM, Cosyns JP, Witjes JA, Kiemeney LA, Tombal B. Somford DM, et al. World J Urol. 2012 Feb;30(1):105-10. doi: 10.1007/s00345-010-0641-4. Epub 2011 Jan 15. World J Urol. 2012. PMID: 21240506 Free PMC article.

7

Relationship between apparent diffusion coefficients at 3.0-T MR imaging and Gleason grade in peripheral zone prostate cancer.

Hambrock T, Somford DM, Huisman HJ, van Oort IM, Witjes JA, Hulsbergen-van de Kaa CA, Scheenen T, Barentsz JO. Hambrock T, et al. Radiology. 2011 May;259(2):453-61. doi: 10.1148/radiol.11091409. Radiology. 2011. PMID: 21502392

8

Prospective assessment of prostate cancer aggressiveness using 3-T diffusion-weighted magnetic resonance imaging-guided biopsies versus a systematic 10-core transrectal ultrasound prostate biopsy cohort.

Hambrock T, Hoeks C, Hulsbergen-van de Kaa C, Scheenen T, Fütterer J, Bouwense S, van Oort I, Schröder F, Huisman H, Barentsz J. Hambrock T, et al. Among authors: van oort i. Eur Urol. 2012 Jan;61(1):177-84. doi: 10.1016/j.eururo.2011.08.042. Epub 2011 Aug 27. Eur Urol. 2012. PMID: 21924545

9

Prostate cancer: multiparametric MR imaging for detection, localization, and staging.

Hoeks CM, Barentsz JO, Hambrock T, Yakar D, Somford DM, Heijmink SW, Scheenen TW, Vos PC, Huisman H, van Oort IM, Witjes JA, Heerschap A, Fütterer JJ. Hoeks CM, et al. Radiology. 2011 Oct;261(1):46-66. doi: 10.1148/radiol.11091822. Radiology. 2011. PMID: 21931141 Review.

10

Prostate brachytherapy and second primary cancer risk: a competitive risk analysis.

Hinnen KA, Schaapveld M, van Vulpen M, Battermann JJ, van der Poel H, van Oort IM, van Roermund JG, Monninkhof EM. Hinnen KA, et al. J Clin Oncol. 2011 Dec 1;29(34):4510-5. doi: 10.1200/JCO.2011.35.0991. Epub 2011 Oct 24. J Clin Oncol. 2011. PMID: 22025166

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

164 results

Search Page